Clinical trials
Phase 1 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
311 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 10 |
| 2011 | 8 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 14 |
| 2016 | 26 |
| 2017 | 23 |
| 2018 | 22 |
| 2019 | 29 |
| 2020 | 24 |
| 2021 | 16 |
| 2022 | 19 |
| 2023 | 22 |
| 2024 | 31 |
| 2025 | 22 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 110 |
| Recruiting | 64 |
| Terminated | 54 |
| Active, not recruiting | 42 |
| Unknown status | 17 |
| Withdrawn | 15 |
| Not yet recruiting | 5 |
| Suspended | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 26 |
| Novartis Pharmaceuticals | 14 |
| AbbVie | 8 |
| Pfizer | 8 |
| AstraZeneca | 7 |
| Eli Lilly and Company | 7 |
| M.D. Anderson Cancer Center | 7 |
| Mayo Clinic | 5 |
| City of Hope Medical Center | 4 |
| Exelixis | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 311 |
| Carcinoma, Non-Small-Cell Lung | 112 |
| Breast Neoplasms | 109 |
| Ovarian Neoplasms | 78 |
| Squamous Cell Carcinoma of Head and Neck | 58 |
| Colorectal Neoplasms | 54 |
| Melanoma | 46 |
| Carcinoma, Renal Cell | 44 |
| Endometrial Neoplasms | 44 |
| Stomach Neoplasms | 43 |
Trials
Showing 1 to 25 of 311. Each trial links to its page on Pharma Observatory.
211 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.